The primary efficacy variable was the final visit tremor score based on the Fahn–Tolosa–Marin Tremor Rating Scale (TRS). Results: The intent-to-treat population was 208 patients (topiramate, 108; placebo, 100). The final visit score (last observation carried forward) was lower in the topiramate group than with placebo (p.
![]()
Mov Disord. Author manuscript; available in PMC 2014 Sep 8.
Published in final edited form as:
Published online 2012 Oct 2. doi: 10.1002/mds.25162
NIHMSID: NIHMS623967
The publisher's final edited version of this article is available at Mov Disord
See other articles in PMC that cite the published article.
Associated Data
Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2022
Categories |